Are surgical care products posing a risk to your health?
53 samples were taken for testing across hospitals, out of which, four products seem to have failed the test.
Zee Media Bureau/Udita Madan
New Delhi: The Drugs Control Department in reply to an RTI query by activist Rajhans Bansal, said that four samples of surgical care products lifted for random tests from Delhi government hospitals till March this year have failed to meet the “standard quality”.
53 samples were taken for testing across hospitals, out of which, four products seem to have failed the test. However, 16 medicines and surgical care products were successful in meeting the desired standard.
As per information given by the department, anti-inflammatory drug Regunac and painkillers Diclofenac and Aspirin obtained from Sanjay Gandhi Memorial Hospital in Mongolpuri, and Atenolol, to treat high blood pressure, and Aspirin from AIIMS failed to clear the test.
Cotton bandage rolls from the state-run Acharya Shree Bhikshu Hospital, Sanjay Gandhi Memorial Hospital, Rao Tula Ram Memorial Hospital and Guru Teg Bahadur Hospital were found to be of “sub-standard” quality.
Anti-parasitic drug Albendazole pandered from Lok Nayak Hospital also failed the test.
According to Deccan Herald, Rajhans Bansal said that, “The sample size is inadequate to give a clear picture of the medicines and other essentials which are not of the desired quality. There is a need to increase the sample size and lift random samples from hospitals across the city so that quality product is mentioned. Most importantly, the status report in 33 cases is pending”.